Clinical Trials Browser

Has results × tivozanib × Genitourinary × Clear all

NCT01885949 2026-02-24

Tivozanib + Enzalutamide in Adv Prostate Cancer

Phase 2 Terminated

5 enrolled 7 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT01673386 2020-10-27

TAURUS

Phase 2 Terminated

58 enrolled 7 charts

Carcinoma, Renal Cell

NCT00502307 2020-09-01

A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma

Phase 2 Completed

272 enrolled 16 charts

Carcinoma, Renal Cell